C3 and nonpapillary renal cell carcinoma: Here, unlike C3AR1, C3 mRNA overexpression was significantly associated with advanced clinical stage, later stages of TNM classification, and poor OS and RFS rates in ccRCC patients, indicating a vital role of C3 in ccRCC carcinogenesis and progression.